Metraipolis › archive › dc_893a091ffcd1

Levetiracetam as First-Line Anti-seizure Medicine in Electrographically Confirmed Neonatal Seizures: A Literature Review — Europe PMC PMID:41717204

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41717204
DOI
10.7759/cureus.101814
License (as archived)
solo-consultazione
Archived
2026-11-06T17:32:41.579Z
SHA-256 of the archived text
697ec17d2c63dc4ef217e90805c38cd62836b3f3f2bf6416df59e0bf4609cc29
Stable URL of this page
https://metraipolis.com/documento/dc_893a091ffcd1

How to cite

Levetiracetam as First-Line Anti-seizure Medicine in Electrographically Confirmed Neonatal Seizures: A Literature Review — Europe PMC PMID:41717204 — Europe PMC (en), https://europepmc.org/article/MED/41717204 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_893a091ffcd1 (Metraipolis archive dc_893a091ffcd1, sha256 697ec17d2c63dc4ef217e90805c38cd62836b3f3f2bf6416df59e0bf4609cc29)
BibTeX
@misc{dc893a091ffcd1,
  title = {Levetiracetam as First-Line Anti-seizure Medicine in Electrographically Confirmed Neonatal Seizures: A Literature Review — Europe PMC PMID:41717204},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41717204},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_893a091ffcd1; sha256 697ec17d2c63dc4ef217e90805c38cd62836b3f3f2bf6416df59e0bf4609cc29},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41717204. Agents can read the archived copy with the MCP tool read_document.